A UK feasibility and validation study of the VE1 monoclonal antibody immunohistochemistry stain for BRAF-V600E mutations in metastatic melanoma

by Lo, Michelle Chin I, Paterson, Anna, Maraka, Jane, Clark, Richard, Goodwill, Joseph, Nobes, Jenny, Garioch, Jennifer, Moncrieff, Marc, Rytina, Ed, Igali, Laszlo
Published 2016

RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases – results and lessons learnt

by Gupta, Avinash, Roberts, Corran, Tysoe, Finn, Goff, Matthew, Nobes, Jenny, Lester, James, Marshall, Ernie, Corner, Carie, Wolstenholme, Virginia, Kelly, Charles, Wise, Adelyn, Collins, Linda, Love, Sharon, Woodward, Martha, Salisbury, Amanda, Middleton, Mark R
Published 2016

Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients

by S. Ahmad, Saif, Qian, Wendi, Ellis, Sarah, Mason, Elaine, Khattak, Muhammad A., Gupta, Avinash, Shaw, Heather, Quinton, Amy, Kovarikova, Jarmila, Thillai, Kiruthikah, Rao, Ankit, Board, Ruth, Nobes, Jenny, Dalgleish, Angus, Grumett, Simon, Maraveyas, Anthony, Danson, Sarah, Talbot, Toby, Harries, Mark, Marples, Maria, Plummer, Ruth, Kumar, Satish, Nathan, Paul, Middleton, Mark R., Larkin, James, Lorigan, Paul, Wheater, Matthew, Ottensmeier, Christian H., Corrie, Pippa G.
Published 2015